Skip to main content
Clinical Trials/NCT04863157
NCT04863157
Completed
Not Applicable

A Sleep Intervention for Children After Cancer: Survivor Sleep Health Information Program (Survivor-SHIP)

Dana-Farber Cancer Institute1 site in 1 country16 target enrollmentMay 24, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Problem
Sponsor
Dana-Farber Cancer Institute
Enrollment
16
Locations
1
Primary Endpoint
Intervention acceptability
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

Detailed Description

This study will evaluate Survivor-SHIP in a single-arm trial of 20 off-treatment childhood cancer survivors (ages 5-12). The intervention is an adapted version of the family-centered Sleep Health Program designed at Seattle Children's Hospital. The program offers parents information about how to utilize evidence-based strategies for their child's sleep, and has demonstrated success in a community-based sample of children with behavioral sleep problems. Sessions will focus on providing parents with education about healthy sleep and setting targets for modifiable behaviors that can improve their child's sleep health. The study will include 3 education sessions taking place over videoconference. Families will be asked to track their child's sleep using sleep diaries during the course of the program. Prior to, and following the program, families will be asked to complete study questionnaires.

Registry
clinicaltrials.gov
Start Date
May 24, 2021
End Date
December 31, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Zhou, PhD

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Child aged 5-12 years, with a history of a cancer diagnosis (except non-melanoma skin cancer).
  • No cancer therapy (excluding chemoprevention) in the past 6 months, and no further therapy planned.
  • Child meets diagnostic criteria for insomnia disorder as determined by insomnia screening criteria (see Appendix A)
  • Parent/guardian is able to read and write in English.
  • Regular access to a computer/smartphone with internet access at home.

Exclusion Criteria

  • Reports child has been diagnosed with a Seizure Disorder or has experienced a seizure in the past 12 months.
  • Reports child has been diagnosed with a developmental disorder such as Autism Spectrum Disorder, Cerebral Palsy, Fragile X Syndrome, or Moderate to Profound Intellectual Disability.
  • Reports child has been diagnosed with sleep apnea, and are not receiving recommended medical treatment for their sleep apnea.
  • Intention to adjust (decrease or increase) child's use of any prescribed or over-the-counter sleep medications during the study period.
  • Any impairment (e.g., hearing, visual, cognitive) that interferes with the parent/guardian's ability to complete all study procedures independently.

Outcomes

Primary Outcomes

Intervention acceptability

Time Frame: 6 weeks

Intervention acceptability will be assessed using the Satisfaction subscale of the Usability, Satisfaction, and Ease of use (USE) scale. Total scores will range from 0-11, with higher scores indicating better acceptability.

Intervention feasibility

Time Frame: 6 weeks

Intervention feasibility will be assessed based on adherence rates to the intervention sessions.

Secondary Outcomes

  • Sleep knowledge(6 weeks)
  • Sleep habits(6 weeks)
  • Sleep quality(6 weeks)
  • General quality of life(6 weeks)
  • Screen time(6 weeks)
  • Sleep change(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials